As the global economy mends, the 2021 growth of Diabetes Associated Ophthalmic Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Diabetes Associated Ophthalmic Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Diabetes Associated Ophthalmic Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Diabetes Associated Ophthalmic Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Diabetes Associated Ophthalmic Treatment market, reaching US$ million by the year 2028. As for the Europe Diabetes Associated Ophthalmic Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Diabetes Associated Ophthalmic Treatment players cover Alcon, Johnson & Johnson Services, Inc., Bausch Health, and F. Hoffmann-La Roche Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Associated Ophthalmic Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Dry Eye Syndrome
Glaucoma
Eye Allergy & Infection
Diabetic Retinopathy
Diabetic associated Macular Degeneration
Uveitis
Cataract
Diabetic Macular Edema
Others
Segmentation by end user: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Ophthalmic Centers
Ambulatory Surgical Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Alcon
Johnson & Johnson Services, Inc.
Bausch Health
F. Hoffmann-La Roche Ltd
Allergan
Bayer AG
Santen Pharmaceutical Co. Ltd.
Novartis AG
Pfizer, Inc.
Genentech, Inc.
Carl Zeiss Meditec
Lumenis
Ellex Medical Lasers Ltd.
IRIDEX Corp.
Topcon Corp.
Abbott Medical Optics
Quantel